Shanghai Rongtai Health Technology Future Growth
Future criteria checks 1/6
Shanghai Rongtai Health Technology is forecast to grow earnings and revenue by 14.3% and 12.9% per annum respectively. EPS is expected to grow by 13.2% per annum. Return on equity is forecast to be 12.9% in 3 years.
Key information
14.3%
Earnings growth rate
13.2%
EPS growth rate
Leisure earnings growth | 24.4% |
Revenue growth rate | 12.9% |
Future return on equity | 12.9% |
Analyst coverage | Low |
Last updated | 17 Apr 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2,757 | 314 | N/A | 384 | 1 |
12/31/2025 | 2,412 | 277 | N/A | 332 | 3 |
12/31/2024 | 2,072 | 240 | N/A | 283 | 2 |
12/31/2023 | 1,855 | 203 | 255 | 344 | N/A |
9/30/2023 | 1,741 | 190 | 151 | 244 | N/A |
6/30/2023 | 1,793 | 183 | 236 | 302 | N/A |
3/31/2023 | 1,826 | 143 | 223 | 285 | N/A |
12/31/2022 | 2,005 | 164 | 136 | 237 | N/A |
9/30/2022 | 2,310 | 173 | 276 | 427 | N/A |
6/30/2022 | 2,466 | 182 | 105 | 248 | N/A |
3/31/2022 | 2,657 | 226 | 98 | 252 | N/A |
12/31/2021 | 2,613 | 236 | 196 | 338 | N/A |
9/30/2021 | 2,480 | 222 | 136 | 259 | N/A |
6/30/2021 | 2,390 | 234 | 391 | 542 | N/A |
3/31/2021 | 2,215 | 232 | 421 | 562 | N/A |
12/31/2020 | 2,021 | 193 | 85 | 276 | N/A |
9/30/2020 | 2,090 | 246 | 58 | 210 | N/A |
6/30/2020 | 2,096 | 258 | -95 | 134 | N/A |
3/31/2020 | 2,129 | 267 | -157 | 79 | N/A |
12/31/2019 | 2,314 | 296 | 285 | 446 | N/A |
9/30/2019 | 2,167 | 274 | 221 | 443 | N/A |
6/30/2019 | 2,157 | 245 | 263 | 359 | N/A |
3/31/2019 | 2,204 | 249 | 222 | 346 | N/A |
12/31/2018 | 2,296 | 249 | 131 | 261 | N/A |
9/30/2018 | 2,398 | 245 | 176 | 278 | N/A |
6/30/2018 | 2,332 | 246 | 153 | 307 | N/A |
3/31/2018 | 2,155 | 220 | 149 | 298 | N/A |
12/31/2017 | 1,918 | 216 | 123 | 281 | N/A |
9/30/2017 | 1,709 | 222 | N/A | 226 | N/A |
6/30/2017 | 1,515 | 217 | N/A | 220 | N/A |
3/31/2017 | 1,370 | 212 | N/A | 241 | N/A |
12/31/2016 | 1,285 | 207 | N/A | 176 | N/A |
9/30/2016 | 1,192 | 196 | N/A | 203 | N/A |
12/31/2015 | 1,024 | 143 | N/A | 215 | N/A |
12/31/2014 | 723 | 62 | N/A | 125 | N/A |
12/31/2013 | 411 | 26 | N/A | 77 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 603579's forecast earnings growth (14.3% per year) is above the savings rate (2.9%).
Earnings vs Market: 603579's earnings (14.3% per year) are forecast to grow slower than the CN market (23.8% per year).
High Growth Earnings: 603579's earnings are forecast to grow, but not significantly.
Revenue vs Market: 603579's revenue (12.9% per year) is forecast to grow slower than the CN market (14.4% per year).
High Growth Revenue: 603579's revenue (12.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 603579's Return on Equity is forecast to be low in 3 years time (12.9%).